PARIS–(BUSINESS WIRE)–Okomera, une société de TechBio qui personnalise la prise en charge du cancer grâce à sa technologie combinant mini‑avatars tumoraux, microfluidique et imagerie par IA, annonce aujourd’hui la signature d’un accord commercial avec Servier, groupe pharmaceutique international indépendant, pour utiliser sa technologie dans le développement de nouveaux traitements contre le cancer. Dans un contexte où plus de 90% des candidats-médicaments en oncologie n’atteignent jamais le
Author: sHq_LoGiNz
PARIS–(BUSINESS WIRE)– #Okomera–Okomera, a TechBio company pioneering personalized cancer care through a proprietary technology platform combining tumor mini-avatars, microfluidics, and AI-powered imaging, today announced the signing of a commercial agreement with Servier, an independent international pharmaceutical group, to use its technology in the development of new cancer treatments. With more than 90% of oncology drug candidates never reaching the market, identifying early on the therapeutic appr
LONDON–(BUSINESS WIRE)– Pershing Square Holdings, Ltd. Announces Transactions in Own Shares – 20 October 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the “Shares”): Total Buyback Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 20 October 2026 Number of Public Shares Purchased: 29
COURBEVOIE, France–(BUSINESS WIRE)–Bureau Veritas (BOURSE:BVI): L’exécution de LEAP | 28 a transformé Bureau Veritas en une société multi-spécialiste plus recentrée, plus performante et à plus forte croissance. Son modèle opérationnel axé sur les Lignes de Produits associe l’échelle mondiale de la Société et sa résilience à des priorités claires, une responsabilisation accrue et une expertise spécialisée approfondie. Il crée ainsi un modèle de croissance plus reproductible, permettant une exé
COURBEVOIE, France–(BUSINESS WIRE)–Bureau Veritas (BOURSE:BVI): The execution of LEAP | 28 has transformed Bureau Veritas into a more focused, faster-growing and higher-performing multi-specialist company. Its Product Line-centric operating model combines the Company’s global scale and resilience with clear priorities, stronger accountability and deep specialist expertise. This creates a more repeatable growth model, enabling faster execution, stronger capabilities and higher conversion of gr
CHENNAI, India–(BUSINESS WIRE)–Vultr, the world’s largest privately-held cloud infrastructure company, today announced a major expansion of its AMD powered infrastructure for enterprise and sovereign cloud initiatives. Vultr will deploy AMD Instinct™ MI355X GPUs in a new 20 MW supercluster in Chennai, India, creating the country’s largest AMD Instinct deployment and giving Vultr two of the world’s largest AMD AI infrastructure deployments globally, alongside its flagship supercluster in Sprin
LUXEMBOURG–(BUSINESS WIRE)–Regulatory News: Eurofins (Paris:ERF): Eurofins delivered steady improvement in both organic and reported revenue growth throughout the first nine months of 2026: Reported revenues in 9M 2026 totalled €5,614m, a 3.7% increase versus 9M 2025. Growth was driven by both organic growth13 and acquisitions, despite a -1.7% headwind from foreign exchange, and a -0.7% headwind from discontinuations and disposals15 as Eurofins exited certain non-core activities. Organic reve
TOKYO–(BUSINESS WIRE)–Beluuga AI, Inc., developer of the beluuga.ai platform, today launched Beluuga Research, an English-language equity research service. It covers 20 Japanese companies now and plans 100% small- and mid-cap coverage within months. Japan has nearly 3,900 listed companies, yet over 70% of TOPIX Small Index stocks have no analyst coverage, and English research is even more scarce. Because research is costly and brokers have little incentive to cover thinly traded stocks, many
MARSEILLE, France–(BUSINESS WIRE)– #Biotech–Innate Pharma to participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference
ZUG, Switzerland–(BUSINESS WIRE)–Galderma (SIX: GALD) will showcase data from its leading innovative Injectable Aesthetics portfolio at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) taking place in Dubai, United Arab Emirates (UAE), from October 21-23, 2026. The company will present eight scientific abstracts, alongside a symposium and six Meet-the-Expert sessions, all highlighting the expanding benefits of Relfydess, Sculptra, and the Restylane range.1-8 Together, the data de
